The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
The closing price of AEON Biopharma Inc (AMEX: AEON) was $0.60 for the day, down -2.68% from the previous closing price of $0.62. In other words, the price has decreased by -$2.68 from its previous closing price. On the day, 0.51 million shares were traded.
Ratios:
Our analysis of AEON’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 1.43 and its Current Ratio is at 1.43.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on August 18, 2023, initiated with a Buy rating and assigned the stock a target price of $18.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on May 21 ’25 when FISCHER JOST bought 60,000 shares for $0.49 per share. The transaction valued at 29,250 led to the insider holds 266,785 shares of the business.
FISCHER JOST bought 60,000 shares of AEON for $30,360 on May 20 ’25. The Director now owns 206,785 shares after completing the transaction at $0.51 per share. On May 19 ’25, another insider, FISCHER JOST, who serves as the Director of the company, bought 50,000 shares for $0.50 each. As a result, the insider paid 24,940 and bolstered with 146,785 shares of the company.
Valuation Measures:
As of this moment, AEON’s Price-to-Earnings (P/E) ratio for their current fiscal year is 0.00.
Stock Price History:
Over the past 52 weeks, AEON has reached a high of $269.28, while it has fallen to a 52-week low of $0.38. The 50-Day Moving Average of the stock is 17.83%, while the 200-Day Moving Average is calculated to be -98.12%.
Shares Statistics:
A total of 11.31M shares are outstanding, with a floating share count of 10.56M. Insiders hold about 6.59% of the company’s shares, while institutions hold 13.50% stake in the company.
Earnings Estimates
The stock of AEON Biopharma Inc (AEON) is currently being evaluated by 1.0 analysts who are actively contributing to its market rating.The consensus estimate for the next quarter is -$0.35, with high estimates of -$0.35 and low estimates of -$0.35.
Analysts are recommending an EPS of between -$0.27 and -$0.27 for the fiscal current year, implying an average EPS of -$0.27.
